Clinical Trials Browser

Interventional × Sarcoma × envafolimab × Clear all

NCT05941325 2025-05-18

A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma

Phase 2 Recruiting

Sarcoma

NCT04480502 2024-05-17

ENVASARC

Phase 2 Active not recruiting

Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT05448820 2023-09-21

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Phase 1/2 Unknown

Diabetes Mellitus, Insulin-Dependent, 12, Chondrosarcoma, Sarcoma